Research Topics
Species | Anthony E LangSummaryAffiliation: University of Toronto Country: Canada Publications
| Collaborators
|
Detail Information
Publications
Deep brain stimulation: preoperative issuesAnthony E Lang
Department of Neurology, Toronto Western Hospital, Toronto, Ontario, Canada
Mov Disord 21:S171-96. 2006..It outlines answers to a series of questions developed to address all aspects of deep brain stimulation preoperative decision-making...
Trial designs used to study neuroprotective therapy in Parkinson's diseaseAnthony E Lang
Morton and Gloria Shulman Movement Disorders Clinic and the Edmond J Safra Program in Parkinson s Disease, Toronto Western Hospital, Toronto, Ontario, Canada
Mov Disord 28:86-95. 2013..2013 Movement Disorder Society...
When and how should treatment be started in Parkinson disease?Anthony E Lang
Toronto Western Hospital, University of Toronto, Canada
Neurology 72:S39-43. 2009..This review will highlight these and other issues that must be considered when deciding on the early treatment of PD...
Randomized controlled trial of intraputamenal glial cell line-derived neurotrophic factor infusion in Parkinson diseaseAnthony E Lang
Toronto Western Hospital, University of Toronto, Ontario, Canada
Ann Neurol 59:459-66. 2006..This randomized controlled clinical trial was designed to confirm initial clinical benefits observed in a small, open-label trial using intraputamenal (Ipu) infusion of recombinant human GDNF (liatermin)...
Challenges in Parkinson's disease: restoration of the nigrostriatal dopamine system is not enoughAnthony E Lang
Movement Disorders Clinic, Toronto Western Hospital, University of Toronto, Toronto, Ontario, Canada
Lancet Neurol 3:309-16. 2004..Knowledge of the widespread, multisystem nature of the neurodegeneration that accounts for these problems suggests that restoration of the nigrostriatal dopamine system should not be the ultimate goal of future research...
A critical appraisal of the premotor symptoms of Parkinson's disease: potential usefulness in early diagnosis and design of neuroprotective trialsAnthony E Lang
University of Toronto, Toronto, Ontario, Canada
Mov Disord 26:775-83. 2011..This article will review the current status of premotor symptoms of Parkinson's disease and discuss their potential for early diagnosis and the design of neuroprotective trials...
Psychogenic movement disorders: past developments, current status, and future directionsAnthony E Lang
Toronto Western Hospital, University of Toronto, Toronto, Ontario, Canada
Mov Disord 26:1175-86. 2011..Given the personal and societal impact of these problems, further advances in our understanding of their pathogenesis and the subsequent development of effective therapies are sorely needed...
Deep brain stimulation for Parkinson's disease: patient selection and evaluationAnthony E Lang
Division of Neurology, Toronto Western Hospital Movement and University of Toronto, Ontario, Canada
Mov Disord 17:S94-101. 2002....
Corticobasal degeneration: selected developmentsAnthony E Lang
Department of Medicine Neurology, University of Toronto, Toronto Western Hospital, Toronto, Ontario, Canada
Mov Disord 18:S51-6. 2003..Even if they are eventually found to be distinct disorders, treatments that alter the progression of one may have similar ameliorative effects on the other. Each of these issues are discussed in this selective review of CBD...
The progression of Parkinson disease: a hypothesisAnthony E Lang
Movement Disorders Centre, Toronto Western Hospital, Toronto, ON, Canada
Neurology 68:948-52. 2007..This hypothesis has implications for the development of disease-modifying therapy and the interpretation of endpoints of clinical trials evaluating the efficacy of such treatments...
Stimulation of the subthalamic nucleus and impulsivity: release your horsesBenedicte Ballanger
Division of Brain, Imaging and Behaviour Systems Neuroscience, Toronto Western Research Institute, University Health Network, University of Toronto, Toronto, Ontario, Canada
Ann Neurol 66:817-24. 2009....
Electrophysiological features of myoclonus-dystoniaJie Yuan Li
Division of Neurology, Department of Medicine, University of Toronto, Toronto, Ontario, Canada
Mov Disord 23:2055-61. 2008....
Beta oscillatory activity in the subthalamic nucleus and its relation to dopaminergic response in Parkinson's diseaseMoran Weinberger
Department of Physiology, Med Sci Building 3302, 1 King's College Circle, University of Toronto, Toronto, Ontario M5S 1A8, Canada
J Neurophysiol 96:3248-56. 2006..The study also suggests that LFP beta oscillatory activity is generated largely within the dorsal portion of the STN and can produce synchronous oscillatory activity of the local neuronal population...
Cerebral blood flow changes induced by pedunculopontine nucleus stimulation in patients with advanced Parkinson's disease: a [(15)O] H2O PET studyBenedicte Ballanger
Toronto Western Research Institute Division of Brain, Imaging and Behaviour Systems Neuroscience, UHN, University of Toronto, Toronto, Ontario, Canada
Hum Brain Mapp 30:3901-9. 2009..Whether these findings are associated with the DBS-PPN clinical effect remains to be proven. However, they suggest that PPN modulation may induce functional changes in neural networks associated with the control of lower limb movements...
Neuronal firing rates and patterns in the globus pallidus internus of patients with cervical dystonia differ from those with Parkinson's diseaseJoyce K H Tang
Department of Physiology, University of Toronto, Toronto, ON, Canada
J Neurophysiol 98:720-9. 2007..These findings suggest that alterations in both firing rate and firing pattern may underlie the differing motor symptoms associated with these two movement disorders...
Involvement of the basal ganglia and cerebellar motor pathways in the preparation of self-initiated and externally triggered movements in humansJamie Purzner
The Krembil Neuroscience Centre and Toronto Western Research Institute, University Health Network, Toronto, Ontario, Canada M5T 2S8
J Neurosci 27:6029-36. 2007..The CTC pathway is involved in the preparation of self-paced but not externally cued movements, although the pathway may still be involved in the execution of these movements...
Involvement of human thalamus in the preparation of self-paced movementGuillermo Paradiso
The Krembil Neuroscience Centre and Toronto Western Research Institute, Toronto, Ontario, Canada
Brain 127:2717-31. 2004..Different cortico-subcortical circuits may mediate alpha and beta oscillations. During movement preparation, the motor thalamus and the supplementary motor area predominantly interact in the beta band...
LRRK2 and Parkin mutations in a family with parkinsonism-Lack of genotype-phenotype correlationConnie Marras
Movement Disorders Centre, Toronto Western Hospital, Toronto, Canada
Neurobiol Aging 31:721-2. 2010..In the combined mutation carriers the age at onset and clinical course was highly variable and not always younger than in the carriers of LRRK2 G2019S mutations alone...
Selective enhancement of rapid eye movement sleep by deep brain stimulation of the human ponsAndrew S Lim
Division of Neurology, Department of Medicine, University of Toronto, Toronto, Ontario, Canada
Ann Neurol 66:110-4. 2009..This represents the first demonstration that DBS can selectively modulate human sleep, and it supports an important role for the pedunculopontine nucleus region in modulating human REM sleep. Ann Neurol 2009;66:110-114...
Predictors of time to requiring dopaminergic treatment in 2 Parkinson's disease cohortsConnie Marras
Morton and Gloria Shulman Movement Disorders Centre, Toronto Western Hospital, Toronto, Ontario, Canada
Mov Disord 26:608-13. 2011..We suspect that individuals employed full time may have a lower threshold for requiring dopaminergic therapy because of occupational demands...
Changes in cortical and pallidal oscillatory activity during the execution of a sensory trick in patients with cervical dystoniaJoyce K H Tang
Department of Physiology, Med Sci Bldg 3302, 1 King s College Circle, University of Toronto, Toronto, Ontario, Canada M5S 1A8
Exp Neurol 204:845-8. 2007..These preliminary findings suggest a role for 4-8 Hz frequency synchronization in the pathophysiology of dystonia...
Levodopa response in long-term bilateral subthalamic stimulation for Parkinson's diseasePanida Piboolnurak
Movement Disorders Center, Division of Neurology, University of Toronto, Toronto Western Hospital, Toronto, Ontario, Canada
Mov Disord 22:990-7. 2007..1% at 3 years and 19.2% at 5 years). Anti-PD drugs were significantly reduced by 47.9% at 3 years and 39.8% at 5 years. However, the magnitude of the preoperative response to levodopa did not predict DBS benefit at 3 and 5 years...
Unilateral subdural motor cortex stimulation improves essential tremor but not Parkinson's diseaseElena Moro
Movement Disorders Centre, Division of Neurology, Department of Medicine, University of Toronto, Toronto Western Hospital, University Health Network, Toronto, ON M5T2S8, Canada
Brain 134:2096-105. 2011..These findings suggest that unilateral subdural motor cortex stimulation may be useful for contralateral hand tremor in selected patients with essential tremor but was not effective in improving parkinsonian signs in our series...
Neuronal activity in the globus pallidus of multiple system atrophy patientsLuiz C M Pereira
Department of Surgery, Division of Neurosurgery, University of Toronto, Toronto, Ontario, Canada
Mov Disord 19:1485-92. 2004....
Subthalamic nucleus deep brain stimulation for parkinson's disease after successful pallidotomy: clinical and electrophysiological observationsGalit Kleiner-Fisman
Division of Neurology, Toronto Western Hospital, University of Toronto, Toronto, Ontario, Canada
Mov Disord 19:1209-14. 2004..017, 0.005). There were no side-to-side differences clinically or in the STN neuronal firing rates and patterns. Bilateral STN DBS is safe and efficacious in improving motor symptoms in patients with prior pallidotomy...
Subdural motor cortex stimulation in Parkinson's disease does not modify movement-related rCBF patternAntonio P Strafella
Movement Disorders Center, Division of Neurology, Toronto Western Hospital, University of Toronto, Toronto, Ontario, Canada
Mov Disord 22:2113-6. 2007..We conclude that while MCS may be a simpler and safer surgical procedure than DBS of STN, it failed to provide evidence of clear effect on motor performance and movement-related activation pattern in patients with advanced PD...
Cortical and spinal abnormalities in psychogenic dystoniaAlberto J Espay
Toronto Western Research Institute, University of Toronto, Toronto, Ontario, Canada
Ann Neurol 59:825-34. 2006..Alternatively, these findings may represent endophenotypic abnormalities that predispose to both types of dystonia...
The nature and time course of cortical activation following subthalamic stimulation in Parkinson's diseaseRenju Kuriakose
Division of Neurology, Department of Medicine, University of Toronto, Toronto, Ontario, Canada M5T 2S8
Cereb Cortex 20:1926-36. 2010..Cortical activation may be related to the clinical effects of STN DBS in PD...
The nonmotor symptoms of Parkinson's disease--an overviewShen Yang Lim
Movement Disorders Centre, Toronto Western Hospital, Ontario, Canada
Mov Disord 25:S123-30. 2010..The increased focus on these important clinical features represents a major advance in the care of PD patients. In this article, we provide an overview of recent developments in the field...
Psychiatric symptoms following surgery for Parkinson's disease with an emphasis on subthalamic stimulationValerie Voon
Department of Psychiatry, Toronto Western Hospital, UHN, Toronto, Canada
Adv Neurol 96:130-47. 2005..The paucity of the literature underscores the need for well-designed studies on psychiatric issues investigating both pathophysiology and clinical outcomes...
Psychiatric symptoms in patients with Parkinson disease presenting for deep brain stimulation surgeryValerie Voon
Department of Psychiatry, Toronto Western Hospital, University Health Network, University of Toronto, Ontario, Canada
J Neurosurg 103:246-51. 2005..In the present study, preoperative psychiatric symptoms were systematically assessed in patients with PD presenting for routine preoperative psychiatric assessment...
Involvement of the cerebellothalamocortical pathway in Parkinson diseaseZhen Ni
Division of Neurology, Department of Medicine, University of Toronto and Toronto Western Research Institute, Krembil Neuroscience Centre, University Health Network, Toronto, Ontario, Canada
Ann Neurol 68:816-24. 2010..We tested whether M1 or cerebellar stimulation can reset PD tremor, and investigated the excitability of the CTC pathway in PD...
Childhood onset in familial prion disease with a novel mutation in the PRNP geneEkaterina Rogaeva
Centre for Research in Neurodegenerative Diseases, Department of Medicine, Toronto, Ontario, Canada
Arch Neurol 63:1016-21. 2006..To our knowledge, the propositus represents the youngest individual with inherited prion disease described to date...
Long-term effect of unilateral pallidotomy on levodopa-induced dyskinesiaGalit Kleiner-Fisman
Morton and Gloria Shulman Movement Disorders Center, Toronto Western Hospital, University of Toronto, Toronto, Ontario, Canada
Mov Disord 25:1496-8. 2010..Though sample size was small, there was a trend towards a reduction in LID lasting up to 12 years suggesting that posteroventral pallidotomy may provide sustained benefit in reducing LID...
Genetic association study of PINK1 coding polymorphisms in Parkinson's diseaseJustus L Groen
Centre for Research in Neurodegenerative Diseases, Department of Medicine, University of Toronto, 6 Queen s Park Crescent West, Toronto, Ont, Canada M5S 3H2
Neurosci Lett 372:226-9. 2004..19). Nevertheless, it remains to be evaluated whether PINK1 variations contribute to the risk of common late onset sporadic PD...
Motor cortex plasticity in Parkinson's disease and levodopa-induced dyskinesiasFrancesca Morgante
Division of Neurology and Toronto Western Research Institute, University Health Network, University of Toronto, Toronto, Ontario, Canada
Brain 129:1059-69. 2006..Abnormal synaptic plasticity in the motor cortex may play a role in the development of LID...
Levodopa-related motor complications--phenomenologySusan H Fox
Division of Neurology, Toronto Western Hospital, Movement Disorders Clinic, University of Toronto, Toronto, Ontario, Canada
Mov Disord 23:S509-14. 2008..These include fluctuations in FD symptoms termed motor fluctuations, as well as non-motor symptoms, termed non-motor fluctuations. Here we review the phenomenology and methods of assessing these levodopa-related complications...
Treatment of progressive supranuclear palsy and corticobasal degenerationAnthony E Lang
Toronto Western Hospital, Movement Disorders Clinic, Ontario, Canada
Mov Disord 20:S83-91. 2005..The similarities in the molecular pathology of these four-repeat tauopathies suggests that important advances in the management of one will have a definite impact on the treatment of the other...
Predictors of deterioration in health-related quality of life in Parkinson's disease: results from the DATATOP trialConnie Marras
Division of Neurology, Toronto Western Hospital, University Health Network, University of Toronto, Toronto, Ontario, Canada
Mov Disord 23:653-9; quiz 776. 2008..Our focus in clinical care needs to be broadened beyond assessing and treating Parkinsonism, recognizing the impact of mood, cognition and function on HRQOL...
Analysis of the PINK1 gene in a large cohort of cases with Parkinson diseaseEkaterina Rogaeva
Centre for Research in Neurodegenerative Diseases and Division of Neurology, Department of Medicine, Toronto Western Hospital, University of Toronto, Ontario, Canada
Arch Neurol 61:1898-904. 2004..Mutations in the PTEN-induced kinase (PINK1) gene located within the PARK6 locus on chromosome 1p35-p36 have recently been identified in patients with recessive early-onset Parkinson disease...
Stimulation of the subthalamic nucleus in Parkinson's disease does not produce striatal dopamine releaseAviva Abosch
Department of Surgery, Morton and Gloria Shulman Movement Disorders Centre, Toronto Western Hospital, and University Health Network, University of Toronto, Toronto, Ontario, Canada
Neurosurgery 53:1095-102; discussion 1102-5. 2003..We sought to determine whether STN stimulation could release endogenous striatal dopamine...
Impairments of speed and amplitude of movement in Parkinson's disease: a pilot studyAlberto J Espay
Toronto Western Research Institute, Division of Neurology, Department of Medicine, University of Toronto, Toronto, Ontario, Canada
Mov Disord 24:1001-8. 2009..Levodopa, however, normalized speed to a greater extent than amplitude. Our observations suggest that amplitude and speed impairments may be associated with different functional aspects in PD and deserve separate clinical assessment...
Overview of the extranigral aspects of Parkinson diseaseShen Yang Lim
Movement Disorders Centre, Toronto Western Hospital, 399 Bathurst St, Toronto, Ontario M5T 2S8, Canada
Arch Neurol 66:167-72. 2009..Later-stage features often contribute markedly to disability and impaired quality of life and, therefore, represent an important future therapeutic challenge...
Subthalamic nucleus stimulation: improvements in outcome with reprogrammingElena Moro
Movement Disorders Center and Department of Neurosurgery, Toronto Western Hospital, University Health Network, University of Toronto, 399 Bathurst Street, Toronto, Ontario
Arch Neurol 63:1266-72. 2006..Even when the electrode is well positioned in the target, the optimization of clinical results depends on careful programming of electrical parameters and changes in antiparkinsonian drug dosages...
rCBF changes associated with PPN stimulation in a patient with Parkinson's disease: a PET studyAntonio P Strafella
Movement Disorders Center, Toronto Western Hospital, Division of Neurology, University of Toronto, Toronto, Ontario, Canada
Mov Disord 23:1051-4. 2008....
Is there seasonal variation in risk of Parkinson's disease?Ronald B Postuma
Department of Neurology, McGill University, Montreal General Hospital, Montreal, Quebec, Canada
Mov Disord 22:1097-101. 2007..We found no evidence of systematic seasonal variation in PD incidence by birth date, or of clustering of birth dates during influenza pandemic years in PD patients...
Pallidal deep brain stimulation influences both reflexive and voluntary saccades in Huntington's diseaseAdrian P Fawcett
Department of Physiology, Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada
Mov Disord 20:371-7. 2005..Our data demonstrate a task-specific improvement of oculomotor deficits in this HD patient with pallidal DBS, supporting a role of GPi in oculomotor control...
Bilateral globus pallidus stimulation for Huntington's diseaseElena Moro
Movement Disorders Center, Toronto Western Hospital, Toronto, Ontario, Canada
Ann Neurol 56:290-4. 2004..Adjustment of stimulation parameters in GPi DBS may have the potential to optimize the motor response in HD, improving chorea without aggravating bradykinesia...
Motor cortical stimulation for parkinsonism in multiple system atrophyGalit Kleiner-Fisman
Division of Neurology and Neurosurgery, Toronto Western Hospital, University of Toronto, Toronto, Ontario
Arch Neurol 60:1554-8. 2003..CONCLUSIONS: Our data suggest that motor cortical stimulation using these parameters fails to improve the motor disability in MSA. Worsening of motor scores was likely a function of disease progression...
Firing rates of pallidal neurons are similar in Huntington's and Parkinson's disease patientsJoyce K H Tang
Department of Physiology, Faculty of Medicine, University of Toronto, Toronto, ON, Canada, M5S 1A8
Exp Brain Res 166:230-6. 2005..Furthermore, the findings did reveal a difference between firing patterns in the HD and PD groups, thereby supporting the role of altered firing patterns in the pathophysiology of these diseases...
Caffeine for treatment of Parkinson disease: a randomized controlled trialRonald B Postuma
Department of Neurology, McGill University, Montreal General Hospital, Montreal, Canada
Neurology 79:651-8. 2012..Epidemiologic studies consistently link caffeine, a nonselective adenosine antagonist, to lower risk of Parkinson disease (PD). However, the symptomatic effects of caffeine in PD have not been adequately evaluated...
Reduced intracortical and interhemispheric inhibitions in corticobasal syndromePramod Kr Pal
Division of Neurology and Toronto Western Research Institute, University Health Network, University of Toronto, Toronto, Ontario, Canada
J Clin Neurophysiol 25:304-12. 2008..In conclusion, CBS patients had deficits in intracortical and interhemispheric inhibition in the representations for both distal and proximal upper limb muscles bilaterally with relative sparing of motor cortical output pathways...
Non-dopaminergic treatments in development for Parkinson's diseaseSusan H Fox
Movement Disorders Clinic, Division of Neurology, University of Toronto, Toronto, ON, Canada
Lancet Neurol 7:927-38. 2008..Here, we review novel non-dopaminergic approaches that are in at least phase II clinical development for the treatment of PD...
Dopamine agonists diminish value sensitivity of the orbitofrontal cortex: a trigger for pathological gambling in Parkinson's disease?Thilo van Eimeren
Division of Brain, Imaging and Behaviour Systems Neuroscience, BIB SN, Toronto Western Research Institute, University of Toronto, Toronto, ON, Canada
Neuropsychopharmacology 34:2758-66. 2009..Our findings raise the question of whether pathological gambling may in part stem from an impaired capacity of the OFC to guide behavior when facing negative consequences...
Orthostatic tremor in progressive supranuclear palsyRob M A De Bie
Movement Disorders Center, Division of Neurology, Toronto Western Hospital, Toronto, Ontario, Canada
Mov Disord 22:1192-4. 2007..quot; We describe a patient with OT, with postural tremor of the arms and restless legs syndrome (RLS), who developed features typical of progressive supranuclear palsy (PSP). PSP can be accompanied by OT...
Rapidly progressive behavioral changes and parkinsonism in a 68-year-old manGalit Kleiner-Fisman
Department of Medicine, Division of Neurology, Toronto Western Hospital, Toronto, Ontario, Canada
Mov Disord 19:534-43. 2004
Homocysteine and levodopa: should Parkinson disease patients receive preventative therapy?Ronald B Postuma
Morton and Gloria Shulman Movement Disorders Center, Toronto Western Hospital, Ontario, Canada
Neurology 63:886-91. 2004..At present, no controlled prospective studies have evaluated this phenomenon, although they are ongoing...
Unilateral versus bilateral tasks in early asymmetric Parkinson's disease: differential effects on bradykinesiaAsha Kishore
Division of Neurology, Department of Medicine, Toronto Western Hospital, Toronto, Ontario, Canada
Mov Disord 22:328-33. 2007..This observation also highlights the need to perform tasks of bradykinesia in one limb at a time for best accuracy...
Extrastriatal dopaminergic dysfunction in tourette syndromeThomas D L Steeves
Division of Neurology, Toronto Western Hospital, University Health Network, University of Toronto, Ontario, Canada
Ann Neurol 67:170-81. 2010..A substantial body of evidence has also accrued to implicate regions outside the striatum in the generation of tics...
Localization of clinically effective stimulating electrodes in the human subthalamic nucleus on magnetic resonance imagingJean A Saint-Cyr
Department of Surgery, Division of Neurosurgery, University of Toronto and University Health Network, Toronto, Ontario, Canada
J Neurosurg 97:1152-66. 2002..The authors sought to determine the location of deep brain stimulation (DBS) electrodes that were most effective in treating Parkinson disease (PD)...
Homozygous and heterozygous PINK1 mutations: considerations for diagnosis and care of Parkinson's disease patientsCindy Zadikoff
Movement Disorders Centre, Toronto Western Hospital, Toronto, Ontario, Canada
Mov Disord 21:875-9. 2006..We describe two unrelated cases with PINK1 mutations (homozygous nonsense and heterozygous missense) that highlight issues regarding the role of heterozygous mutations and the utility of genetic screening in patient care...
Analysis of the glucocerebrosidase gene in Parkinson's diseaseChristine Sato
Centre for Research in Neurodegenerative Diseases, University of Toronto, Toronto, Ontario, Canada
Mov Disord 20:367-70. 2005..Our results demonstrate a marginally significant association of GBA mutations with PD and suggest that variations in the GBA gene may constitute a rare susceptibility factor for PD (P = 0.048)...
Long-term follow-up of thalamic deep brain stimulation for essential and parkinsonian tremorRajeev Kumar
Division of Neurology, Faculty of Medicine, University of Toronto, Canada
Neurology 61:1601-4. 2003..Two of five patients with essential tremor had contralateral tremor improvement after ongoing stimulation for 2 years; two developed marked tolerance to DBS...
Long-term follow up of bilateral deep brain stimulation of the subthalamic nucleus in patients with advanced Parkinson diseaseGalit Kleiner-Fisman
Division of Neurology and Neurosurgery, Toronto Western Hospital, University of Toronto, Ontario, Canada
J Neurosurg 99:489-95. 2003..Improvements in tremor, rigidity, and bradykinesia were more marked and better sustained over time than improvements in axial symptoms. A good preoperative response to levodopa predicted a good response to surgery...
Characterization of REM-sleep associated ponto-geniculo-occipital waves in the human ponsAndrew S Lim
Division of Neurology, Department of Medicine, University of Toronto, Ontario, Canada
Sleep 30:823-7. 2007..We sought to identify and characterize human PGO waves...
Primary dystonia is more responsive than secondary dystonia to pallidal interventions: outcome after pallidotomy or pallidal deep brain stimulationHazem A Eltahawy
Division of Neurosurgery, Toronto Western Hospital, Toronto, Ontario, Canada
Neurosurgery 54:613-19; discussion 619-21. 2004..The presence of basal ganglia abnormalities on the preoperative magnetic resonance imaging scan is an indicator of a lesser response to pallidal interventions for dystonia...
Long-term results of a multicenter study on subthalamic and pallidal stimulation in Parkinson's diseaseElena Moro
Toronto Western Hospital, Movement Disorders Center, University of Toronto and University Health Network, Toronto, Ontario, Canada
Mov Disord 25:578-86. 2010..Although the surgical targets were not randomized, there was a trend to a better outcome of motor signs in the STN-DBS patients and fewer adverse events in the GPi-DBS group...
Dependence of subthalamic nucleus oscillations on movement and dopamine in Parkinson's diseaseRon Levy
Department of Physiology, University of Toronto, Toronto, Canada
Brain 125:1196-209. 2002....
Neonatal ablation of the nigrostriatal dopamine pathway does not influence limb development in ratsMatthew O Hebb
Division of Neurosurgery, University of Toronto, Toronto, Ontario, M5T 2S8, Canada
Exp Neurol 177:547-56. 2002..The results of this study indicate that early skeletal development in rats is not affected by loss of nigrostriatal dopamine per se, but is markedly attenuated by corticospinal lesions sustained during the neonatal period...
Myoclonus in parkinsonian disordersMohamed Shafiq
Department of Medicine (Neurology, Toronto Western Hospital, Toronto, Ontario, Canada
Adv Neurol 89:77-83. 2002
Translational research in neurology and neuroscience 2011: movement disordersChristine Klein
Section of Clinical and Molecular Neurogenetics, Department of Neurology, University of Lubeck, Lubeck, Germany
Arch Neurol 68:709-16. 2011..Aetiology and pathogenesis, biomarker directions, and causal treatment opportunities are discussed for each disease, followed by a brief discussion drawing attention to important translational initiatives...
Deep brain stimulation for Parkinson's disease dissociates mood and motor circuits: a functional MRI case studyTaresa Stefurak
Rotman Research Institute, University of Toronto, Toronto, Ontario, Canada
Mov Disord 18:1508-16. 2003....
Pallidal neuronal activity: implications for models of dystoniaWilliam D Hutchison
Department of Surgery, Division of Neurosurgery and Toronto Western Research Institute, Toronto Western Hospital and Faculty of Medicine, University of Toronto, Ontario, Canada
Ann Neurol 53:480-8. 2003..The widely accepted pathophysiological models of dystonia that propose global decreases in basal ganglia output need to be viewed with caution in light of these findings...
Tongue control for swallowing in Parkinson's disease: effects of age, rate, and stimulus consistencyPascal H H M van Lieshout
Department of Speech Language Pathology, University of Toronto, and Toronto Western Hospital Research Institute, University Health Network, Toronto, Ontario, Canada
Mov Disord 26:1725-9. 2011..Efficient swallows require well-coordinated tongue movements during bolus flow, but little is known about such movements in Parkinson's disease...
A comparison of treatment thresholds in two large Parkinson's disease clinical trial cohortsConnie Marras
Morton and Gloria Shulman Movement Disorders Centre, Toronto Western Hospital, Toronto, Ontario, Canada
Mov Disord 24:2370-8. 2009..This may relate to changes in philosophies with respect to starting treatment for Parkinson's disease, but the factors underlying this change remain to be elucidated...
Punding prevalence in Parkinson's diseaseJanis M Miyasaki
Movement Disorders Centre, Toronto Western Hospital, University Health Network, Krembil Neuroscience Centre, University of Toronto, Toronto, Canada
Mov Disord 22:1179-81. 2007..4%) in contrast with previous reports of 14%. Despite the low incidence, this behavior is disruptive and should be carefully elicited by physicians caring for Parkinson's disease patients...
Antipsychotic use in older adults with Parkinson's diseaseConnie Marras
Morton and Gloria Shulman Movement Disorders Centre, Toronto Western Hospital, University Health Network, Toronto, Canada
Mov Disord 22:319-23. 2007..Typical antipsychotics are still commonly being chosen as first-line agents for older patients, indicating a need for interventions to improve practice...
Does severity of Parkinson's disease vary according to season?Ronald B Postuma
Department of Neurology, McGill University, Montreal General Hospital, Montreal, Quebec, Canada
Mov Disord 20:476-9. 2005..We found no evidence for seasonal fluctuation in the UPDRS scores, suggesting that, although considerable day-to-day variation may exist in PD, there is little monthly or seasonal variation...
Antidepressants in the treatment of psychosis with comorbid depression in Parkinson diseaseValerie Voon
University of Toronto, Toronto Western Hospital University Health Network, Ontario, Canada
Clin Neuropharmacol 27:90-2. 2004..Potential mechanisms implicated in the response of psychosis to antidepressants are discussed...
Clinical findings in a large family with a parkin ex3delta40 mutationRenato P Munhoz
Movement Disorders Centre, Toronto Western Hospital, and Centre for Research in Neurodegenerative Diseases, University of Toronto, Toronto, Ontario, Canada
Arch Neurol 61:701-4. 2004..CONCLUSION: In families with a dominant inheritance, an additional genetic or environmental cause must coexist with the Ex3Delta40 mutation...
Progress in clinical neurosciences: a forum on the early management of Parkinson's diseaseAnthony E Lang
Division of Neurology, Department of Medicine, University of Toronto, Toronto Western Hospital, Canada
Can J Neurol Sci 32:277-86. 2005..This report summarizes presentations and discussion dealing with these issues from a one-day symposium involving Canadian Movement Disorders neurologists...
Corticobasal degeneration syndrome with basal ganglia calcification: Fahr's disease as a corticobasal look-alike?Anthony E Lang
Movement Disorders Centre, Toronto Western Hospital, Toronto, Canada
Mov Disord 18:351-2; author reply 352. 2003
Combination of dopamine transporter and D2 receptor SPECT in the diagnostic evaluation of PD, MSA, and PSPYun J Kim
Morton and Gloria Shulman Movement Disorders Center and the Division of Neurology (Department of Medicine, The Toronto Western Hospital, Toronto, Ontario, Canada
Mov Disord 17:303-12. 2002..These findings suggest that DAT SPECT may be useful in differentiating parkinsonism from controls and D2 SPECT in further differentiating MSA from Parkinson's disease and possibly PSP...
Subthalamic stimulation for Parkinson's disease--living better electrically?Anthony E Lang
University of Toronto, Toronto
N Engl J Med 349:1888-91. 2003
Apraxia in movement disordersCindy Zadikoff
Morton and Gloria Shulman Movement Disorders Center, Toronto Western Hospital, University of Toronto, Toronto, Ontario, Canada
Brain 128:1480-97. 2005..Finally, although apraxia results in clear disability in patients with the CBS, it is not clear how milder ideomotor apraxia found on specific testing contributes to patients' overall day-to-day motor disability...
Neurodegenerative disease and the evolution of art: the effects of presumed corticobasal degeneration in a professional artistGalit Kleiner-Fisman
Morton and Gloria Shulman Movement Disorders Center, Division of Neurology, The Toronto Hospital, University of Toronto, Western Division, 399 Bathurst Street, MP11-306, Toronto, Ontario M5T 2S8, Canada
Mov Disord 18:294-302. 2003..Our case study adds to the growing literature on the effects of brain damage on artistic expression in the graphic arts...
Large deletions account for an increasing number of mutations in SGCEFabin Han
Ottawa Health Research Institute, Ottawa, Ontario, Canada
Mov Disord 23:456-60. 2008..This is only the second report of intragenic deletions with SGCE and it highlights the need to include exonic copy number variation when performing mutational analysis of SGCE...
Criteria for deep-brain stimulation in Parkinson's disease: review and analysisElena Moro
University of Toronto, Department of Medicine, Movement Disorders Center, 399 Bathurst Street, McL7 402, Canada
Expert Rev Neurother 6:1695-705. 2006..The recent observation that deep-brain stimulation of the pedunculopontine nucleus improves axial signs, possibly even in those less responsive to levodopa, brings new hope to the management of advanced Parkinson's disease...
Rapidly progressive sporadic dentatorubral pallidoluysian atrophy with intracytoplasmic inclusions and no CAG repeat expansionAlberto J Espay
Toronto Western Research Institute, Division of Neurology, Department of Medicine, University of Toronto, Toronto, Ontario, Canada
Mov Disord 21:2251-4. 2006..This case expands the clinical and neuropathological spectrum of DRPLA and supports the hypothesis that aggregates may not be intrinsically pathogenic...
Pathological gambling in Parkinson's disease improves on chronic subthalamic nucleus stimulationClaire Ardouin
, CHU Grenoble, INSERM U318, , Grenoble, France
Mov Disord 21:1941-6. 2006....
Subthalamic nucleus deep brain stimulation: summary and meta-analysis of outcomesGalit Kleiner-Fisman
Parkinson s Disease Research Education and Clinical Center, Philadelphia VA Hospital, Philadelphia, Pennsylvania 19104, USA
Mov Disord 21:S290-304. 2006..These data provide an estimate of the magnitude of the treatment effects and emphasize the need for controlled and randomized studies...
Excessive daytime sleepiness and sudden-onset sleep in Parkinson disease: a survey by the Canadian Movement Disorders GroupDouglas E Hobson
Department of Medicine, University of Maitoba, Winnipeg
JAMA 287:455-63. 2002..The frequency of these spells and whether driving should be restricted has yet to be established...
Phenotypic spectrum and sex effects in eleven myoclonus-dystonia families with epsilon-sarcoglycan mutationsDeborah Raymond
The Alan and Barbara Mirken Department of Neurology, Beth Israel Medical Center, New York, New York 10003, USA
Mov Disord 23:588-92. 2008..0097). We found no association between mutation type and phenotype...
Antidepressants and psychosis in Parkinson disease: a case seriesValerie Voon
Int J Geriatr Psychiatry 22:601-4. 2007
Sporadic case of dentatorubral pallidoluysian atrophy with no CAG repeat expansion and no intranuclear inclusionsRenato P Munhoz
Movement Disorders Centre, Toronto Western Hospital, University of Toronto, Toronto, Ontario, Canada
Mov Disord 19:580-3. 2004..Family history and genetic testing were unrevealing. Neuropathological findings were identical to genetic dentatorubral pallidoluysian (DRPLA) except for the lack of intranuclear inclusions...
Serum urate as a predictor of clinical and radiographic progression in Parkinson diseaseMichael A Schwarzschild
MassGeneral Institute for Neurodegenerative Disease, Massachusetts General Hospital, Boston, USA
Arch Neurol 65:716-23. 2008..To determine whether concentration of serum urate, a purine metabolite and potent antioxidant that has been linked to a reduced risk of Parkinson disease (PD), predicts prognosis in PD...
Phenotype, genotype, and worldwide genetic penetrance of LRRK2-associated Parkinson's disease: a case-control studyDaniel G Healy
Department of Clinical Neurosciences, Institute of Neurology, University College London, London, UK
Lancet Neurol 7:583-90. 2008..LRRK2-associated PD be distinguished from idiopathic PD; which mutations in LRRK2 are pathogenic; and what is the age-specific cumulative risk of PD for individuals who inherit or are at risk of inheriting a deleterious mutation in LRRK2?..
A comparison of the mini mental state exam to the Montreal cognitive assessment in identifying cognitive deficits in Parkinson's diseaseCindy Zadikoff
Department of Neurology, Northwestern University, Parkinson s Disease and Movement Disorders Center, Chicago, Illinois, USA
Mov Disord 23:297-9. 2008..000002). Compared to the MMSE, the MoCA may be a more sensitive tool to identify early cognitive impairment in PD...
Ten-year follow-up of Parkinson's disease patients randomized to initial therapy with ropinirole or levodopaRobert A Hauser
Parkinson s Disease and Movement Disorders Center, University of South Florida, Tampa, Florida 33606, USA
Mov Disord 22:2409-17. 2007..Early treatment decisions for individual patients depend largely on the anticipated risk of side effects and long-term complications. Both ropinirole and levodopa are viable treatment options in early PD...
Sustained relief of dystonia following cessation of deep brain stimulationMatthew O Hebb
Division of Neurosurgery, Department of Surgery, Dalhousie University, Halifax, Nova Scotia, Canada
Mov Disord 22:1958-62. 2007....
Time to move beyond nigrostriatal dopamine deficiency in Parkinson's diseaseAnthony E Lang
Ann Neurol 55:761-5. 2004
